Savient Pharmaceuticals, Inc. to Present At Citi Investment Research Global Healthcare Conference On May 22nd

EAST BRUNSWICK, N.J., May 13, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, Senior Vice President, Commercial Operations of Savient Pharmaceuticals will present a corporate update at the upcoming Citi Investment Research Global Healthcare Conference.

MORE ON THIS TOPIC